Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Matern Fetal Neonatal Med. 2015 Apr 20;29(6):855–862. doi: 10.3109/14767058.2015.1022864

Table 1.

Plasma concentrations (percentile for gestational age) of angiogenic and anti-angiogenic factors.

Gestational age (weeks + d) sVEGFR-1 (pg/mL) (percentile) PlGF (pg/mL) (percentile) sEng (ng/mL) (percentile) PlGF/s VEGFR-1 (percentile)
13+3 5664 (98th) 60 (59th) 9.8 (96th) 0.01 (4th)
15+4 4897 (98th) 100 (60th) 11.8 (98th) 0.02 (6th)
17+4 4480 (96th) 157 (62th) 11.3 (98th) 0.03 (10th)
19+5 4148 (93th) 306 (76th) 13.1 (98th) 0.07 (23th)
21+6 1889 (56th) 644 (93th) 8.7 (94th) 0.34 (90th)
25+3 2854 (80th) 768 (79th) 8.8 (94 th) 0.27 (51th)
27+4 3881 (90th) 869 (74th) 9.9 (95th) 0.22 (34th)
29+4 4684 (93th) 821 (65th) 12.7 (97th) 0.18 (25th)
31+4 6370 (97th) 536 (44th) 9.6 (85th) 0.08 (10th)
33+5 11202 (99th) 528 (46th) 12.7 (85th) 0.04 (6th)

sVEGFR-1, soluble vascular endothelial growth factors receptor-1; PlGF, placental growth factor; sEng, soluble endoglin.

Percentile distribution was based on a published reference range [20].